3/6/20 SHR # 2480 : Continuing Education Series: Hitting The Right Targets of Biologic Aging

By Elizabeth F. Yurth, MD | Longevity

Mar 28

The concept of measuring the difference between chronologic and biologic aging is a new phenomenon. First it was telomere length, but that hasn’t proven to be accurate. Many new metrics have since followed. Few have panned out to be accurate as we dive deeper. Often in science its not the obvious or sexy stuff that has real meaning. It’s usually the things right under our nose that have been around for decades, and thus, often ignored. What if the targets to accurately measure biologic aging are already in our hands? Today we will discuss a new program that is offered to laypeople that unlocks the target markers of biologic aging. Understanding these will help provide accurate data-points to assess if what you are doing is actually working. We will also explain how you can become certified yourself.

Listen to the Podcast here.

Contact Us!

Questions About Peptides?

Boulder Longevity Institute is home to the nation's 1st Medically Managed Peptide Program for Human Optimization. If you're interested in learning more, give us a call today. (303)443-0848

About the Author

Along with her almost 25 years in practice in non-surgical orthopedics, and her Stanford-affiliated Fellowship in Sports and Spine Medicine, Dr. Yurth has received her American Board of Anti-Aging/Regenerative Medicine (ABAARM) Board Certification from the American Academy of Anti-Aging Medicine (A4M), has completed her Fellowship in Anti-Aging and Regenerative Medicine (FAARM) and her Advanced Fellowship in Anti-Aging, Regenerative and Functional Medicine (FAARFM) also through A4M. She has also completed an independent fellowship in Epigenetic and Human Potential Medicine and is now part of the nation's very first cohort of Certified Peptide Specialiist through A4M. Dr. Yurth is an inaugural member of the International Peptide Society (IPS) and is an IPS/A4M faculty member and lecturer.